Destruction of basement membranes and neovascularization are critical processes tumor progression which often coincide upon the transition of an in situ carcinoma from the prevascular to the vascularized state. The long term objective of the proposed research is to elucidate the involvement of heparanase and extracellular matrix (ECM)-bound endothelial cell (EC) growth factors in tumor metastasis and angiogenesis. We have previously demonstrated that the capacity of various normal and malignant cells to extravasate correlates with heparanase mediated degradation of heparan sulfate (HS) in subendothelial ECM. It was found that basement membranes contain and sequester angiogenic EC growth factors that are structurally related to basic fibroblast growth factor (bFGF) and are released upon degradation of the ECM HS by heparanase. The proposed research is presented in two interrelated major goals: 1) Characterization of normal and malignant cell heparanases and their involvement in cell invasion and tumor metastasis; and II) Characterization and physiological significance of ECM storage and release of FGF.
The specific aims of the first series of experiments are; 1) purification and characterization of heparanases from a human hepatoma cell line (SK-hep_1 ) and normal human neutrophils; 2) preparation of anti-heparanase antibodies for the purpose of detection, quantitation and localization of heparanase in blood samples, malignant effusions and biopsy specimens and for studies on the involvement of heparanase in tumor metastasis; and 3) investigation of heparanase expression in normal T-lymphocytes and its involvement in cell traffic.
Specific aims of part II are to study: 1) involvement of ECM HS-bound FGF in EC proliferation: 2) deposition interaction with HS, and in-vivo localization of ECM-bound FGF; and 3) involvement of heparanase and heparin-like molecules in FGF release from basement membranes: possible role in neovascularization. The methodology for achieving these goals includes advanced techniques for EC culture and preparation of ECM; biochemical and immunological methods for characterization, detection and localization of heparanase and EC growth factors and use of PF-HR9 cells transfected with various FGF expression constructs to study deposition and function of ECM-bound bFGF. Some of the results are expected to have potential clinical applications in cancer metastasis and vascular diseases.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA030289-07A2
Application #
3169200
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1981-09-30
Project End
1992-07-31
Budget Start
1989-08-04
Budget End
1990-07-31
Support Year
7
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Hadassah-Hebrew University Medical Center
Department
Type
DUNS #
600063937
City
Jerusalem
State
Country
Israel
Zip Code
91120
Benezra, M; Vlodavsky, I; Bar-Shavit, R (1993) Prothrombin conversion to thrombin by plasminogen activator residing in the subendothelial extracellular matrix. Semin Thromb Hemost 19:405-11
Korner, G; Bjornsson, T D; Vlodavsky, I (1993) Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators. J Cell Physiol 154:456-65
Eisenberg, S; Sehayek, E; Olivecrona, T et al. (1992) Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix. J Clin Invest 90:2013-21
Ekre, H P; Naparstek, Y; Lider, O et al. (1992) Anti-inflammatory effects of heparin and its derivatives: inhibition of complement and of lymphocyte migration. Adv Exp Med Biol 313:329-40
Ishai-Michaeli, R; Svahn, C M; Weber, M et al. (1992) Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrix. Biochemistry 31:2080-8
Vlodavsky, I; Ishai-Michaeli, R; Mohsen, M et al. (1992) Modulation of neovascularization and metastasis by species of heparin. Adv Exp Med Biol 313:317-27
Bashkin, P; Neufeld, G; Gitay-Goren, H et al. (1992) Release of cell surface-associated basic fibroblast growth factor by glycosylphosphatidylinositol-specific phospholipase C. J Cell Physiol 151:126-37
Benezra, M; Vlodavsky, I; Yayon, A et al. (1992) Reversal of basic fibroblast growth factor-mediated autocrine cell transformation by aromatic anionic compounds. Cancer Res 52:5656-62
Benezra, M; Vlodavsky, I; Bar-Shavit, R (1992) Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase. Exp Cell Res 201:208-15
Vlodavsky, I; Eldor, A; Haimovitz-Friedman, A et al. (1992) Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis 12:112-27

Showing the most recent 10 out of 61 publications